Search results
Author(s):
Jolanta Siller-Matula
,
Mamas A Mamas
,
Kimberly Atianzar
,
et al
Added:
3 years ago
A substantial number of patients develop a subclinical leaflet thrombosis (SLT) after transcatheter aortic valve replacement (TAVR).
The thrombus forms on the leaflets, which can lead to valve dysfunction and possibly to early valve degeneration. Multidetector computed tomography is the most sensitive imaging technique at detecting SLT.
Patients on antiplatelet drugs are at higher risk to…
View more
Author(s):
Braghadheeswar Thyagarajan
,
Ankur Kalra
,
Alefiyah Rajabali
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM), with a reported prevalence of AF in HCM of about 25 %.1 Patients with AF in HCM tend to be more symptomatic and have an increased stroke risk compared with patients without HCM.2 While the occurrence and treatment of (symptomatic) AF in HCM have been extensively studied, there is little data…
View more
Author(s):
Naima Maqsood
,
Jeff Healey
Added:
4 months ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of…
View more
Author(s):
Ahmad Younes
,
Guilherme Ferragut Attizzani
,
Ankur Kalra
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1
As…
View more
Author(s):
Payam Pournazari
,
Su Min Chang
,
Stephen H Little
,
et al
Added:
1 year ago
Marielle Scherrer-Crosbie
Job title: Director
Author
Author(s):
Ole De Backer
Added:
4 years ago
Prof Ole De Backer (Rigshospitalet, Copenhagen, DK) provides an update from theGALILEO-4D trial, discussing the comparison ofa Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves.
What is the GALILEO-4D study and how is it related to the main GALILEO trial?
What is the design of the study and what…
View more
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
3 months ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more